FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 212 filers reported holding FIBROGEN INC in Q3 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $401,494 | -58.7% | 449,954 | +8.7% | 0.00% | – |
| Q1 2024 | $972,581 | +191.6% | 413,864 | +10.0% | 0.00% | – |
| Q4 2023 | $333,495 | -56.4% | 376,277 | -57.6% | 0.00% | – |
| Q3 2023 | $764,952 | -86.6% | 886,489 | -58.0% | 0.00% | -100.0% |
| Q2 2023 | $5,705,581 | -32.7% | 2,113,178 | +365.4% | 0.00% | -33.3% |
| Q1 2023 | $8,472,144 | +18.8% | 454,027 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $7,130,327 | +40.2% | 445,089 | +13.9% | 0.00% | +50.0% |
| Q3 2022 | $5,085,000 | +16.1% | 390,853 | -5.8% | 0.00% | 0.0% |
| Q2 2022 | $4,380,000 | +412.9% | 414,823 | +484.3% | 0.00% | – |
| Q1 2022 | $854,000 | -55.2% | 71,000 | -47.4% | 0.00% | – |
| Q4 2021 | $1,905,000 | +64.9% | 135,073 | +19.6% | 0.00% | – |
| Q3 2021 | $1,155,000 | -95.7% | 112,975 | -88.9% | 0.00% | -100.0% |
| Q2 2021 | $27,071,000 | +1763.1% | 1,016,544 | +2328.0% | 0.01% | – |
| Q1 2021 | $1,453,000 | -85.6% | 41,868 | -84.6% | 0.00% | -100.0% |
| Q4 2020 | $10,079,000 | +246.1% | 271,761 | +283.8% | 0.01% | +150.0% |
| Q3 2020 | $2,912,000 | -36.5% | 70,814 | -37.4% | 0.00% | -33.3% |
| Q2 2020 | $4,586,000 | +2181.6% | 113,144 | +1852.4% | 0.00% | – |
| Q1 2020 | $201,000 | -95.6% | 5,795 | -94.6% | 0.00% | -100.0% |
| Q4 2019 | $4,577,000 | +714.4% | 106,709 | +602.0% | 0.01% | +500.0% |
| Q3 2019 | $562,000 | -29.8% | 15,201 | -14.3% | 0.00% | 0.0% |
| Q2 2019 | $801,000 | -45.9% | 17,734 | -27.2% | 0.00% | -66.7% |
| Q3 2018 | $1,481,000 | +230.6% | 24,372 | +151.3% | 0.00% | +200.0% |
| Q1 2018 | $448,000 | +64.1% | 9,700 | +68.2% | 0.00% | 0.0% |
| Q4 2017 | $273,000 | -71.2% | 5,766 | -67.3% | 0.00% | -66.7% |
| Q3 2017 | $948,000 | +237.4% | 17,613 | +102.4% | 0.00% | +200.0% |
| Q2 2017 | $281,000 | -0.7% | 8,703 | -34.5% | 0.00% | -50.0% |
| Q1 2016 | $283,000 | +1.4% | 13,294 | +45.2% | 0.00% | 0.0% |
| Q4 2015 | $279,000 | -1.4% | 9,156 | -23.9% | 0.00% | 0.0% |
| Q2 2015 | $283,000 | – | 12,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 1,735,677 | $93,379,000 | 12.44% |
| Omega Fund Management, LLC | 314,348 | $16,912,000 | 9.57% |
| Opaleye Management Inc. | 360,000 | $19,368,000 | 6.85% |
| NEXTHERA CAPITAL LP | 217,329 | $11,692,000 | 3.01% |
| Monashee Investment Management LLC | 122,300 | $6,580,000 | 2.49% |
| Hillhouse Capital Management | 2,486,196 | $133,757,000 | 2.21% |
| DOHENY ASSET MANAGEMENT /CA | 50,925 | $2,740,000 | 1.26% |
| Sicart Associates LLC | 31,072 | $1,672,000 | 1.20% |
| Iguana Healthcare Management, LLC | 80,000 | $4,304,000 | 1.19% |
| Rhenman & Partners Asset Management AB | 145,500 | $7,828,000 | 1.00% |